US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VYNE Therapeutics Inc.

1.34

-0.0696-4.94%

Volume:31.78K

Turnover:42.90K

Market Cap:19.88M

PE:-1.43

High:1.40

Open:1.40

Low:1.34

Close:1.41

Loading ...

Overview Company News Filings

Vyne Therapeutics Price Target Maintained With a $5.75/Share by HC Wainwright & Co.

BRIEF-Vyne Therapeutics Initiates Phase 1B Trial Of Vyn202, A Novel Bd2-Selective Oral Bet Inhibitor, In Plaque Psoriasis

VYNE Therapeutics Receives Buy Rating: Promising Clinical Advances in Plaque Psoriasis Treatment

Vyne Therapeutics Initiates Phase 1B Trial of Vyn202, a Novel Bd2-Selective Oral Bet Inhibitor, in Plaque Psoriasis

THOMSON REUTERS

VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis

3 US Penny Stocks To Watch With Market Caps Over $20M

Simply Wall St.

VYNE Therapeutics (VYNE) Receives a Buy from TD Cowen

EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo…

Zacks Small Cap Research

BRIEF-Vyne Therapeutics Cash Runway Extends Into Second Half Of 2026

Vyne Therapeutics Inc - Cash Runway Extends Into Second Half of 2026

THOMSON REUTERS

VYNE Therapeutics (VYNE) Gets a Buy from BTIG

Buy Rating Justified for VYNE Therapeutics Due to Promising Repibresib Developments and Competitive Advantages

Promising Advancements of VYNE Therapeutics’ VYN201 Drive Buy Rating

BRIEF-Vyne Therapeutics Completes Enrollment In Phase 2B Trial Evaluating VYN201

Vyne Therapeutics Completes Enrollment in Phase 2B Trial Evaluating Vyn201 for the Treatment of Nonsegmental Vitiligo

THOMSON REUTERS

Vyne Therapeutics Inc - Top-Line Data From Vyn201 Trial Expected in Mid-2025

THOMSON REUTERS

VYNE Therapeutics Completes Enrollment in Phase 2b Trial Evaluating VYN201 for the Treatment of Nonsegmental Vitiligo

BTIG Initiates a Buy Rating on VYNE Therapeutics (VYNE)

Analysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and Lyell Immunopharma (LYEL)

Promising Developments in VYNE Therapeutics’ VYN202 Support Buy Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VYNE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VYNE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VYNE\",,,,,undefined,":{"symbol":"VYNE","market":"US","secType":"STK","nameCN":"VYNE Therapeutics Inc.","latestPrice":1.3404,"timestamp":1746020077956,"preClose":1.41,"halted":0,"volume":31778,"delay":0,"floatShares":10204647,"shares":14830013,"eps":-0.935311,"marketStatus":"Trading","change":-0.0696,"latestTime":"04-30 09:34:43 EDT","open":1.4,"high":1.4,"low":1.34,"amount":42902.572127,"amplitude":0.042553,"askPrice":1.36,"askSize":200,"bidPrice":1.33,"bidSize":140,"shortable":3,"etf":0,"ttmEps":-0.935311,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"listingDate":1516856400000,"exchange":"NASDAQ","adjPreClose":1.41,"postHourTrading":{"tag":"盘后","latestPrice":1.41,"preClose":1.41,"latestTime":"18:16 EDT","volume":1,"amount":1.41,"timestamp":1745964963106},"volumeRatio":5.568184,"impliedVol":3.8705,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VYNE\",,,,,undefined,":{"symbol":"VYNE","floatShares":10204647,"roa":"-33.14%","roe":"-56.54%","lyrEps":-0.935311,"volumeRatio":5.568184,"shares":14830013,"dividePrice":0,"high":1.4,"amplitude":0.042553,"preClose":1.41,"low":1.34,"week52Low":1.28,"pbRate":"0.38","psRate":"39.68","week52High":4.3,"institutionHeld":0,"latestPrice":1.3404,"committee":-0.176471,"eps":-0.935311,"divideRate":0,"volume":31778,"delay":0,"ttmEps":-0.935311,"open":1.4,"prevYearClose":3.35,"prevWeekClose":1.43,"prevMonthClose":1.58,"prevQuarterClose":1.58,"fiveDayClose":1.84,"twentyDayClose":1.53,"sixtyDayClose":2.32},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VYNE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512841444","title":"Vyne Therapeutics Price Target Maintained With a $5.75/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2512841444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512841444?lang=en_us&edition=fundamental","pubTime":"2025-02-20 00:22","pubTimestamp":1739982120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VYNE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 19, 2025 11:22 ET (16:22 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","VYNE"],"gpt_icon":0},{"id":"2512485353","title":"BRIEF-Vyne Therapeutics Initiates Phase 1B Trial Of Vyn202, A Novel Bd2-Selective Oral Bet Inhibitor, In Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485353","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512485353?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:02","pubTimestamp":1739977360,"startTime":"0","endTime":"0","summary":"BRIEF-Vyne Therapeutics Initiates Phase 1B Trial Of Vyn202, A Novel Bd2-Selective Oral Bet Inhibitor, In Plaque PsoriasisFeb 19 (Reuters) - Vyne Therapeutics Inc VYNE.O:VYNE THERAPEUTICS INITIATES PHA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA53TT1V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2512485899","title":"VYNE Therapeutics Receives Buy Rating: Promising Clinical Advances in Plaque Psoriasis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485899","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512485899?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:45","pubTimestamp":1739976312,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $5.7...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vyne-therapeutics-receives-buy-rating-promising-clinical-advances-in-plaque-psoriasis-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vyne-therapeutics-receives-buy-rating-promising-clinical-advances-in-plaque-psoriasis-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYNE"],"gpt_icon":0},{"id":"2512101621","title":"Vyne Therapeutics Initiates Phase 1B Trial of Vyn202, a Novel Bd2-Selective Oral Bet Inhibitor, in Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2512101621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512101621?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA53TT1V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2512839104","title":"VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2512839104","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512839104?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasis Top-line data from the 12-week double-blind trial expected by year-end 2025 Phase 1b trial designe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/19/3028700/0/en/VYNE-Therapeutics-Initiates-Phase-1b-Trial-of-VYN202-a-Novel-BD2-Selective-Oral-BET-Inhibitor-in-Plaque-Psoriasis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IBD","VYNE"],"gpt_icon":0},{"id":"2511854019","title":"3 US Penny Stocks To Watch With Market Caps Over $20M","url":"https://stock-news.laohu8.com/highlight/detail?id=2511854019","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511854019?lang=en_us&edition=fundamental","pubTime":"2025-02-13 21:11","pubTimestamp":1739452278,"startTime":"0","endTime":"0","summary":"As U.S. markets face pressure from rising yields and inflation concerns, investors are re-evaluating their strategies to navigate these challenging conditions. While the term \"penny stocks\" may seem outdated, it still signifies smaller or emerging companies that could offer substantial growth potential. By focusing on those with strong financial foundations, investors can uncover opportunities in this segment of the market that might be overlooked by others.Overview: B.O.S. Better Online Solutions Ltd. offers intelligent robotics, RFID, and supply chain solutions to enterprises globally, with a market cap of $21.72 million.Overview: VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing proprietary therapeutics for treating immuno-inflammatory conditions, with a market cap of $36.44 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-us-penny-stocks-watch-131118187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PHX","SB","BABB","ZEPP","BOSC","BK4020","BK4157","BK4021","PVL","VYNE","BK4209","BK4563","BK4213"],"gpt_icon":0},{"id":"2507495243","title":"VYNE Therapeutics (VYNE) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2507495243","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507495243?lang=en_us&edition=fundamental","pubTime":"2025-01-31 20:46","pubTimestamp":1738327605,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Stacy Ku maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $5.00. The company’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vyne-therapeutics-vyne-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vyne-therapeutics-vyne-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TD","BK4007","BK4127","BK4585","VYNE","COWN","BK4566","BK4207"],"gpt_icon":0},{"id":"2505784177","title":"EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo…","url":"https://stock-news.laohu8.com/highlight/detail?id=2505784177","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505784177?lang=en_us&edition=fundamental","pubTime":"2025-01-22 19:23","pubTimestamp":1737544980,"startTime":"0","endTime":"0","summary":"Edesa Biotech, Inc.  is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease that causes areas of the skin to lose color, with non-segmental vitiligo being characterized by patches appearing on both sides of the body. It is caused when pigment-producing cells  die or stop producing melanin as a result of an autoimmune disease, genetics, or a triggering event .A 2022 publication reported that the estimated prevalence of vitiligo patients in the U.S. is between 1.9 million and 2.8 million . This corresponds to a vitiligo market is projected to reach approximately $1 billion by 2030 . In support of this, the following two transactions show the potential for vitiligo treatments in development:. The company is continuing IND-enabling work in 2025 and has already received approval from Health Canada to conduct a Phase 2 tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/edsa-ind-expected-2025-eb06-112300368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","USAW.SI","TQQQ","QID","SIF","BK4187","BK4550","BK4588","SQQQ","USJW.SI","BK4007","BK4585","EDSA","NQmain","INCY","NVIW.SI","MNQmain","QLD",".IXIC","VYNE","BK4139","BK4213","BK4532","ARDS","SOC","TSYW.SI"],"gpt_icon":1},{"id":"2503021693","title":"BRIEF-Vyne Therapeutics Cash Runway Extends Into Second Half Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2503021693","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503021693?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:52","pubTimestamp":1736776335,"startTime":"0","endTime":"0","summary":"BRIEF-Vyne Therapeutics Cash Runway Extends Into Second Half Of 2026Jan 13 (Reuters) - Vyne Therapeutics Inc VYNE.O:VYNE THERAPEUTICS INC - CASH RUNWAY EXTENDS INTO SECOND HALF OF 2026Further company coverage: VYNE.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O913K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2503306452","title":"Vyne Therapeutics Inc - Cash Runway Extends Into Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2503306452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503306452?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:56","pubTimestamp":1736772976,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O913K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2501790155","title":"VYNE Therapeutics (VYNE) Gets a Buy from BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2501790155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501790155?lang=en_us&edition=fundamental","pubTime":"2025-01-08 14:15","pubTimestamp":1736316922,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report), with a price targe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vyne-therapeutics-vyne-gets-a-buy-from-btig?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vyne-therapeutics-vyne-gets-a-buy-from-btig?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2501255244","title":"Buy Rating Justified for VYNE Therapeutics Due to Promising Repibresib Developments and Competitive Advantages","url":"https://stock-news.laohu8.com/highlight/detail?id=2501255244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501255244?lang=en_us&edition=fundamental","pubTime":"2025-01-06 23:15","pubTimestamp":1736176519,"startTime":"0","endTime":"0","summary":"VYNE Therapeutics (VYNE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Rami Katkhuda from...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-justified-for-vyne-therapeutics-due-to-promising-repibresib-developments-and-competitive-advantages?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-justified-for-vyne-therapeutics-due-to-promising-repibresib-developments-and-competitive-advantages?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYNE"],"gpt_icon":0},{"id":"2501255714","title":"Promising Advancements of VYNE Therapeutics’ VYN201 Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2501255714","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501255714?lang=en_us&edition=fundamental","pubTime":"2025-01-06 23:05","pubTimestamp":1736175916,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $5.7...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-advancements-of-vyne-therapeutics-vyn201-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-advancements-of-vyne-therapeutics-vyn201-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYNE"],"gpt_icon":0},{"id":"2501236321","title":"BRIEF-Vyne Therapeutics Completes Enrollment In Phase 2B Trial Evaluating VYN201","url":"https://stock-news.laohu8.com/highlight/detail?id=2501236321","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501236321?lang=en_us&edition=fundamental","pubTime":"2025-01-06 20:42","pubTimestamp":1736167373,"startTime":"0","endTime":"0","summary":"BRIEF-Vyne Therapeutics Completes Enrollment In Phase 2B Trial Evaluating VYN201Jan 6  - Vyne Therapeutics Inc VYNE.O:VYNE THERAPEUTICS COMPLETES ENROLLMENT IN PHASE 2B TRIAL EVALUATING VYN201 FOR THE TREATMENT OF NONSEGMENTAL VITILIGOVYNE THERAPEUTICS INC - TOP-LINE DATA FROM VYN201 TRIAL EXPECTED IN MID-2025Source text: nGNX41cC3vFurther company coverage: VYNE.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA3CMJ7G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2501956235","title":"Vyne Therapeutics Completes Enrollment in Phase 2B Trial Evaluating Vyn201 for the Treatment of Nonsegmental Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2501956235","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501956235?lang=en_us&edition=fundamental","pubTime":"2025-01-06 20:30","pubTimestamp":1736166600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA3CMJ7G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2501235951","title":"Vyne Therapeutics Inc - Top-Line Data From Vyn201 Trial Expected in Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501235951","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501235951?lang=en_us&edition=fundamental","pubTime":"2025-01-06 20:30","pubTimestamp":1736166600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA3CMJ7G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2501123518","title":"VYNE Therapeutics Completes Enrollment in Phase 2b Trial Evaluating VYN201 for the Treatment of Nonsegmental Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2501123518","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501123518?lang=en_us&edition=fundamental","pubTime":"2025-01-06 20:30","pubTimestamp":1736166600,"startTime":"0","endTime":"0","summary":"Once-daily VYN201 gel being evaluated in subjects with nonsegmental vitiligo. Top-line data from the 24-week double-blind portion of the trial expected in mid-2025. “Repibresib” approved as the non-proprietary name for VYN201 by USAN. BRIDGEWATER, N.J., Jan. 06, 2025  -- VYNE Therapeutics Inc.  , a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today announced completion of enrollment in the Phase 2b trial evaluating VYN201 gel for the treatment of nonsegmental vitiligo. Top-line data from the 24-week vehicle-controlled treatment period are expected in mid-2025.About VitiligoVitiligo is a chronic autoimmune depigmenting disorder of the skin, characterized by the loss of pigment producing cells known as melanocytes. Vitiligo is th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vyne-therapeutics-completes-enrollment-phase-123000292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2500498337","title":"BTIG Initiates a Buy Rating on VYNE Therapeutics (VYNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500498337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500498337?lang=en_us&edition=fundamental","pubTime":"2025-01-01 18:25","pubTimestamp":1735727111,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison initiated coverage with a Buy rating on VYNE Therapeutics (VYNE – Research Report) on December 30 and set a price targ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-initiates-a-buy-rating-on-vyne-therapeutics-vyne?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-initiates-a-buy-rating-on-vyne-therapeutics-vyne?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYNE"],"gpt_icon":0},{"id":"2493089700","title":"Analysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and Lyell Immunopharma (LYEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2493089700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493089700?lang=en_us&edition=fundamental","pubTime":"2024-12-24 21:30","pubTimestamp":1735047059,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on VYNE Therapeutics (VYNE – Research Report) and Lye...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vyne-therapeutics-vyne-and-lyell-immunopharma-lyel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vyne-therapeutics-vyne-and-lyell-immunopharma-lyel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4137","BK4007","BK4139","VYNE","LYEL","BK4539","BK4505"],"gpt_icon":0},{"id":"2493799375","title":"Promising Developments in VYNE Therapeutics’ VYN202 Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2493799375","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493799375?lang=en_us&edition=fundamental","pubTime":"2024-12-24 02:15","pubTimestamp":1734977714,"startTime":"0","endTime":"0","summary":"Rami Katkhuda, an analyst from LifeSci Capital, maintained the Buy rating on VYNE Therapeutics (VYNE – Research Report). The associated price targe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-developments-in-vyne-therapeutics-vyn202-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-developments-in-vyne-therapeutics-vyn202-support-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYNE"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":64,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VYNE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-06","symbol":"VYNE","fiscalQuarterEnding":"2024/12","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"pre","actualEps":-0.28},{"market":"US","date":"2024-11-07","symbol":"VYNE","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2024-08-14","symbol":"VYNE","fiscalQuarterEnding":"2024/06","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.22},{"market":"US","date":"2024-05-09","symbol":"VYNE","fiscalQuarterEnding":"2024/03","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2024-02-29","symbol":"VYNE","fiscalQuarterEnding":"2023/12","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1709182800000,"reportTimeType":"pre","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VYNE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VYNE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1731988800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VYNE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VYNE","date":"2025-04-29","current":-0.536105,"percent":0.718344,"low":-3.249061,"twenty":-1.179955,"median":-0.816084,"eighty":-0.453672,"high":-0.209883,"avg":-0.896321,"sd":0.518118,"marketCap":21355218},"quantilePoints":[{"date":"2020-05-01","current":-1.136259,"twenty":-16.499865,"median":-6.97175,"eighty":-2.778299,"marketCap":108146899},{"date":"2020-05-08","current":-1.251811,"twenty":-16.414246,"median":-6.94825,"eighty":-2.772891,"marketCap":119144888},{"date":"2020-05-15","current":-1.915649,"twenty":-16.345257,"median":-6.900717,"eighty":-2.7643,"marketCap":230274469},{"date":"2020-05-22","current":-2.539086,"twenty":-16.26613,"median":-6.863805,"eighty":-2.748976,"marketCap":305215864},{"date":"2020-05-29","current":-2.709114,"twenty":-16.186098,"median":-6.799386,"eighty":-2.746269,"marketCap":325654427},{"date":"2020-06-05","current":-2.794985,"twenty":-16.08354,"median":-6.736847,"eighty":-2.735531,"marketCap":335976715},{"date":"2020-06-12","current":-2.900449,"twenty":-15.974324,"median":-6.640251,"eighty":-2.733323,"marketCap":348654329},{"date":"2020-06-19","current":-3.249061,"twenty":-15.948222,"median":-6.519027,"eighty":-2.733323,"marketCap":390559896},{"date":"2020-06-26","current":-2.440282,"twenty":-15.84755,"median":-6.425676,"eighty":-2.729662,"marketCap":293338978},{"date":"2020-07-02","current":-2.356615,"twenty":-15.789417,"median":-4.395709,"eighty":-2.725462,"marketCap":283281641},{"date":"2020-07-10","current":-2.328726,"twenty":-15.668756,"median":-4.218616,"eighty":-2.716228,"marketCap":279929195},{"date":"2020-07-17","current":-2.510004,"twenty":-15.631022,"median":-4.180668,"eighty":-2.707537,"marketCap":301720092},{"date":"2020-07-24","current":-2.286893,"twenty":-15.559608,"median":-4.128748,"eighty":-2.704817,"marketCap":274900527},{"date":"2020-07-31","current":-2.245059,"twenty":-15.521402,"median":-4.048131,"eighty":-2.698227,"marketCap":269871860},{"date":"2020-08-07","current":-1.008064,"twenty":-15.416119,"median":-3.978275,"eighty":-2.689761,"marketCap":270820319},{"date":"2020-08-14","current":-1.004943,"twenty":-15.335927,"median":-3.946651,"eighty":-2.685289,"marketCap":269981868},{"date":"2020-08-21","current":-0.948766,"twenty":-15.260479,"median":-3.927677,"eighty":-2.682509,"marketCap":254889713},{"date":"2020-08-28","current":-0.923798,"twenty":-15.146631,"median":-3.901334,"eighty":-2.671563,"marketCap":248182088},{"date":"2020-09-04","current":-0.842654,"twenty":-15.10232,"median":-3.86791,"eighty":-2.657906,"marketCap":226382311},{"date":"2020-09-11","current":-0.942524,"twenty":-15.031719,"median":-3.823319,"eighty":-2.64737,"marketCap":253212808},{"date":"2020-09-18","current":-1.142264,"twenty":-14.989672,"median":-3.793665,"eighty":-2.637635,"marketCap":306873800},{"date":"2020-09-25","current":-0.948766,"twenty":-14.924212,"median":-3.763233,"eighty":-2.626973,"marketCap":254889713},{"date":"2020-10-02","current":-1.004943,"twenty":-14.88239,"median":-3.709443,"eighty":-2.586391,"marketCap":269981868},{"date":"2020-10-09","current":-1.167232,"twenty":-14.866007,"median":-3.670217,"eighty":-2.572592,"marketCap":313581424},{"date":"2020-10-16","current":-1.22965,"twenty":-14.809411,"median":-3.64701,"eighty":-2.566086,"marketCap":330350484},{"date":"2020-10-23","current":-1.173473,"twenty":-14.782583,"median":-3.584263,"eighty":-2.551935,"marketCap":315258329},{"date":"2020-10-30","current":-0.998701,"twenty":-14.749752,"median":-3.491108,"eighty":-2.538031,"marketCap":268304960},{"date":"2020-11-06","current":-1.040671,"twenty":-14.674813,"median":-3.446314,"eighty":-2.525469,"marketCap":281196643},{"date":"2020-11-13","current":-1.049991,"twenty":-14.554638,"median":-3.422836,"eighty":-2.516299,"marketCap":283714821},{"date":"2020-11-20","current":-1.037565,"twenty":-14.39517,"median":-3.396092,"eighty":-2.505874,"marketCap":280357249},{"date":"2020-11-27","current":-1.06863,"twenty":-14.323371,"median":-3.372894,"eighty":-2.49309,"marketCap":288751178},{"date":"2020-12-04","current":-1.056204,"twenty":-14.113343,"median":-3.341543,"eighty":-2.477779,"marketCap":285393609},{"date":"2020-12-11","current":-1.056204,"twenty":-14.008856,"median":-3.315409,"eighty":-2.467235,"marketCap":285393609},{"date":"2020-12-18","current":-1.11212,"twenty":-13.910205,"median":-3.284302,"eighty":-2.443983,"marketCap":300502680},{"date":"2020-12-24","current":-1.099694,"twenty":-13.65471,"median":-3.265694,"eighty":-2.427721,"marketCap":297145110},{"date":"2020-12-31","current":-0.981648,"twenty":-13.013323,"median":-3.250235,"eighty":-2.413195,"marketCap":265248175},{"date":"2021-01-08","current":-1.018926,"twenty":-12.35855,"median":-3.213688,"eighty":-2.40737,"marketCap":275320892},{"date":"2021-01-15","current":-1.037565,"twenty":-12.191081,"median":-3.200919,"eighty":-2.393322,"marketCap":280357249},{"date":"2021-01-22","current":-1.168037,"twenty":-12.109055,"median":-3.14863,"eighty":-2.382446,"marketCap":315611754},{"date":"2021-01-29","current":-1.384759,"twenty":-11.862978,"median":-3.136459,"eighty":-2.365482,"marketCap":374171655},{"date":"2021-02-05","current":-1.923277,"twenty":-11.661331,"median":-3.106342,"eighty":-2.356615,"marketCap":519682856},{"date":"2021-02-12","current":-2.012457,"twenty":-11.275895,"median":-3.096642,"eighty":-2.336596,"marketCap":543779945},{"date":"2021-02-19","current":-1.633604,"twenty":-11.165759,"median":-3.083564,"eighty":-2.328726,"marketCap":441411227},{"date":"2021-02-26","current":-1.417056,"twenty":-10.93677,"median":-3.068303,"eighty":-2.300906,"marketCap":382898574},{"date":"2021-03-05","current":-1.341635,"twenty":-10.594996,"median":-3.059947,"eighty":-2.292423,"marketCap":342878872},{"date":"2021-03-12","current":-1.484233,"twenty":-10.48001,"median":-3.038779,"eighty":-2.284444,"marketCap":379322586},{"date":"2021-03-19","current":-1.570596,"twenty":-10.302539,"median":-3.028301,"eighty":-2.262253,"marketCap":401394131},{"date":"2021-03-26","current":-1.375778,"twenty":-10.239551,"median":-3.02295,"eighty":-2.241171,"marketCap":351604833},{"date":"2021-04-01","current":-1.389837,"twenty":-10.193445,"median":-3.017822,"eighty":-2.223736,"marketCap":355197875},{"date":"2021-04-09","current":-1.206065,"twenty":-10.009739,"median":-3.013643,"eighty":-2.182502,"marketCap":308231681},{"date":"2021-04-16","current":-1.073509,"twenty":-9.848225,"median":-3.01141,"eighty":-2.139594,"marketCap":274354429},{"date":"2021-04-23","current":-1.040369,"twenty":-9.715151,"median":-3.004507,"eighty":-2.096665,"marketCap":265885114},{"date":"2021-04-30","current":-0.992167,"twenty":-9.57099,"median":-2.993653,"eighty":-2.057047,"marketCap":253566111},{"date":"2021-05-07","current":-0.790781,"twenty":-9.464437,"median":-2.988527,"eighty":-2.019718,"marketCap":186533330},{"date":"2021-05-14","current":-0.768996,"twenty":-9.307407,"median":-2.973993,"eighty":-2.016125,"marketCap":181394672},{"date":"2021-05-21","current":-0.797316,"twenty":-9.088041,"median":-2.961564,"eighty":-2.00909,"marketCap":188074929},{"date":"2021-05-28","current":-0.860492,"twenty":-9.034767,"median":-2.956664,"eighty":-1.983332,"marketCap":202977041},{"date":"2021-06-04","current":-0.83435,"twenty":-8.915696,"median":-2.952644,"eighty":-1.958936,"marketCap":196810648},{"date":"2021-06-11","current":-0.869219,"twenty":-8.847055,"median":-2.942392,"eighty":-1.931817,"marketCap":205035664},{"date":"2021-06-18","current":-0.792971,"twenty":-8.77346,"median":-2.932241,"eighty":-1.915649,"marketCap":187050079},{"date":"2021-06-25","current":-0.814756,"twenty":-8.724832,"median":-2.931017,"eighty":-1.830504,"marketCap":192188819},{"date":"2021-07-02","current":-0.712367,"twenty":-8.679459,"median":-2.922421,"eighty":-1.719354,"marketCap":168036745},{"date":"2021-07-09","current":-0.675333,"twenty":-8.632472,"median":-2.91025,"eighty":-1.696044,"marketCap":159300892},{"date":"2021-07-16","current":-0.586015,"twenty":-8.613657,"median":-2.901383,"eighty":-1.634928,"marketCap":138232064},{"date":"2021-07-23","current":-0.588193,"twenty":-8.536797,"median":-2.889685,"eighty":-1.57294,"marketCap":138745938},{"date":"2021-07-30","current":-0.588193,"twenty":-8.353588,"median":-2.873597,"eighty":-1.52256,"marketCap":138745938},{"date":"2021-08-06","current":-0.568587,"twenty":-8.178118,"median":-2.866758,"eighty":-1.484233,"marketCap":134121073},{"date":"2021-08-13","current":-1.037593,"twenty":-8.08413,"median":-2.857125,"eighty":-1.418198,"marketCap":91691068},{"date":"2021-08-20","current":-0.833572,"twenty":-7.903737,"median":-2.845136,"eighty":-1.391042,"marketCap":73661925},{"date":"2021-08-27","current":-0.961814,"twenty":-7.719277,"median":-2.841842,"eighty":-1.376983,"marketCap":84994530},{"date":"2021-09-03","current":-0.973472,"twenty":-7.614348,"median":-2.832842,"eighty":-1.344447,"marketCap":86024764},{"date":"2021-09-10","current":-0.91518,"twenty":-7.505957,"median":-2.828213,"eighty":-1.290219,"marketCap":80873582},{"date":"2021-09-17","current":-0.91518,"twenty":-7.410428,"median":-2.823772,"eighty":-1.251811,"marketCap":80873582},{"date":"2021-09-24","current":-0.868547,"twenty":-7.337406,"median":-2.820901,"eighty":-1.204683,"marketCap":76752635},{"date":"2021-10-01","current":-0.816084,"twenty":-7.28943,"median":-2.813137,"eighty":-1.182212,"marketCap":72116569},{"date":"2021-10-08","current":-0.722818,"twenty":-7.248677,"median":-2.803676,"eighty":-1.168357,"marketCap":63874677},{"date":"2021-10-15","current":-0.711159,"twenty":-7.059479,"median":-2.801189,"eighty":-1.153641,"marketCap":62844439},{"date":"2021-10-22","current":-0.664526,"twenty":-7.031634,"median":-2.794238,"eighty":-1.136022,"marketCap":58723492},{"date":"2021-10-29","current":-0.781109,"twenty":-6.971721,"median":-2.791095,"eighty":-1.130204,"marketCap":69025859},{"date":"2021-11-05","current":-0.798597,"twenty":-6.934155,"median":-2.784895,"eighty":-1.114191,"marketCap":70571215},{"date":"2021-11-12","current":-0.819087,"twenty":-6.887177,"median":-2.778299,"eighty":-1.101481,"marketCap":69573268},{"date":"2021-11-19","current":-0.674172,"twenty":-6.845688,"median":-2.776816,"eighty":-1.093481,"marketCap":57264150},{"date":"2021-11-26","current":-0.648969,"twenty":-6.786853,"median":-2.76863,"eighty":-1.081055,"marketCap":55123435},{"date":"2021-12-03","current":-0.573487,"twenty":-6.736796,"median":-2.758037,"eighty":-1.073603,"marketCap":48711989},{"date":"2021-12-10","current":-0.945101,"twenty":-6.637611,"median":-2.748976,"eighty":-1.067361,"marketCap":80276847},{"date":"2021-12-17","current":-0.680472,"twenty":-6.515916,"median":-2.738843,"eighty":-1.056204,"marketCap":57799329},{"date":"2021-12-23","current":-0.705675,"twenty":-6.447458,"median":-2.729662,"eighty":-1.05469,"marketCap":59940044},{"date":"2021-12-31","current":-0.642668,"twenty":-4.394445,"median":-2.724423,"eighty":-1.0476,"marketCap":54588256},{"date":"2022-01-07","current":-0.642668,"twenty":-4.232531,"median":-2.716799,"eighty":-1.039814,"marketCap":54588256},{"date":"2022-01-14","current":-0.432919,"twenty":-4.186992,"median":-2.707537,"eighty":-1.037565,"marketCap":36772148},{"date":"2022-01-21","current":-0.396942,"twenty":-4.155847,"median":-2.705387,"eighty":-1.031352,"marketCap":33716273},{"date":"2022-01-28","current":-0.35624,"twenty":-4.059051,"median":-2.698383,"eighty":-1.02991,"marketCap":30259017},{"date":"2022-02-04","current":-0.355988,"twenty":-3.997265,"median":-2.694472,"eighty":-1.024845,"marketCap":30237610},{"date":"2022-02-11","current":-0.321838,"twenty":-3.955664,"median":-2.686908,"eighty":-1.018926,"marketCap":27336940},{"date":"2022-02-18","current":-0.345529,"twenty":-3.935196,"median":-2.682509,"eighty":-1.011185,"marketCap":29349215},{"date":"2022-02-25","current":-0.338409,"twenty":-3.909968,"median":-2.679178,"eighty":-1.010595,"marketCap":28744462},{"date":"2022-03-04","current":-0.318688,"twenty":-3.877127,"median":-2.665675,"eighty":-1.006189,"marketCap":27069351},{"date":"2022-03-11","current":-0.37804,"twenty":-3.846508,"median":-2.648422,"eighty":-0.992459,"marketCap":32110738},{"date":"2022-03-18","current":-0.557361,"twenty":-3.807602,"median":-2.641684,"eighty":-0.987315,"marketCap":40870705},{"date":"2022-03-25","current":-0.56785,"twenty":-3.768129,"median":-2.630148,"eighty":-0.978135,"marketCap":41639887},{"date":"2022-04-01","current":-0.557755,"twenty":-3.725227,"median":-2.586391,"eighty":-0.95579,"marketCap":40899622},{"date":"2022-04-08","current":-0.466741,"twenty":-3.681738,"median":-2.575153,"eighty":-0.944586,"marketCap":34225674},{"date":"2022-04-14","current":-0.417449,"twenty":-3.661837,"median":-2.570012,"eighty":-0.930013,"marketCap":30611100},{"date":"2022-04-22","current":-0.361689,"twenty":-3.62775,"median":-2.559572,"eighty":-0.924291,"marketCap":26522294},{"date":"2022-04-29","current":-0.331246,"twenty":-3.517056,"median":-2.544777,"eighty":-0.91518,"marketCap":24289932},{"date":"2022-05-06","current":-0.32257,"twenty":-3.464103,"median":-2.537327,"eighty":-0.905139,"marketCap":23653770},{"date":"2022-05-13","current":-0.47919,"twenty":-3.429547,"median":-2.519013,"eighty":-0.893063,"marketCap":23053362},{"date":"2022-05-20","current":-0.481598,"twenty":-3.412794,"median":-2.509924,"eighty":-0.886285,"marketCap":23169179},{"date":"2022-05-27","current":-0.455959,"twenty":-3.386705,"median":-2.494508,"eighty":-0.878443,"marketCap":21935728},{"date":"2022-06-03","current":-0.536245,"twenty":-3.358585,"median":-2.485189,"eighty":-0.868547,"marketCap":25798223},{"date":"2022-06-10","current":-0.579578,"twenty":-3.327529,"median":-2.469292,"eighty":-0.862718,"marketCap":27882929},{"date":"2022-06-17","current":-0.613385,"twenty":-3.30169,"median":-2.453216,"eighty":-0.858028,"marketCap":29509346},{"date":"2022-06-24","current":-0.602539,"twenty":-3.270101,"median":-2.43376,"eighty":-0.843636,"marketCap":28987570},{"date":"2022-07-01","current":-0.526619,"twenty":-3.253695,"median":-2.414398,"eighty":-0.834039,"marketCap":25335136},{"date":"2022-07-08","current":-0.586512,"twenty":-3.219634,"median":-2.411769,"eighty":-0.826801,"marketCap":28216500},{"date":"2022-07-15","current":-0.542165,"twenty":-3.20842,"median":-2.398449,"eighty":-0.817886,"marketCap":26083016},{"date":"2022-07-22","current":-0.572292,"twenty":-3.152577,"median":-2.382446,"eighty":-0.810334,"marketCap":27532396},{"date":"2022-07-29","current":-0.520715,"twenty":-3.137014,"median":-2.37056,"eighty":-0.805388,"marketCap":25051057},{"date":"2022-08-05","current":-0.500228,"twenty":-3.11322,"median":-2.356615,"eighty":-0.792971,"marketCap":24065482},{"date":"2022-08-12","current":-0.499189,"twenty":-3.098806,"median":-2.338463,"eighty":-0.791973,"marketCap":18300754},{"date":"2022-08-19","current":-0.506467,"twenty":-3.083138,"median":-2.328726,"eighty":-0.782079,"marketCap":18567580},{"date":"2022-08-26","current":-0.51327,"twenty":-3.068199,"median":-2.300837,"eighty":-0.775312,"marketCap":18817004},{"date":"2022-09-02","current":-0.459633,"twenty":-3.060085,"median":-2.292423,"eighty":-0.76707,"marketCap":16850614},{"date":"2022-09-09","current":-0.458842,"twenty":-3.044121,"median":-2.28687,"eighty":-0.757108,"marketCap":16821611},{"date":"2022-09-16","current":-0.433527,"twenty":-3.031386,"median":-2.275251,"eighty":-0.740528,"marketCap":15893524},{"date":"2022-09-23","current":-0.379731,"twenty":-3.024093,"median":-2.242296,"eighty":-0.734476,"marketCap":13921333},{"date":"2022-09-30","current":-0.352992,"twenty":-3.017822,"median":-2.223736,"eighty":-0.724046,"marketCap":12941039},{"date":"2022-10-07","current":-0.379731,"twenty":-3.013643,"median":-2.180807,"eighty":-0.71514,"marketCap":13921333},{"date":"2022-10-14","current":-0.383687,"twenty":-3.01142,"median":-2.137877,"eighty":-0.703155,"marketCap":14066348},{"date":"2022-10-21","current":-0.379731,"twenty":-3.004923,"median":-2.094948,"eighty":-0.687415,"marketCap":13921333},{"date":"2022-10-28","current":-0.397927,"twenty":-2.994938,"median":-2.056158,"eighty":-0.680472,"marketCap":14588398},{"date":"2022-11-04","current":-0.440172,"twenty":-2.988713,"median":-2.018082,"eighty":-0.673765,"marketCap":16137145},{"date":"2022-11-11","current":-0.630717,"twenty":-2.9754,"median":-2.015737,"eighty":-0.663292,"marketCap":15663868},{"date":"2022-11-18","current":-0.54402,"twenty":-2.96311,"median":-2.00909,"eighty":-0.65275,"marketCap":13510737},{"date":"2022-11-25","current":-0.535374,"twenty":-2.956803,"median":-1.983332,"eighty":-0.647028,"marketCap":13296004},{"date":"2022-12-02","current":-0.531401,"twenty":-2.952644,"median":-1.957575,"eighty":-0.64014,"marketCap":13197343},{"date":"2022-12-09","current":-0.485716,"twenty":-2.944274,"median":-1.931817,"eighty":-0.630067,"marketCap":12062745},{"date":"2022-12-16","current":-0.394695,"twenty":-2.934195,"median":-1.915649,"eighty":-0.62345,"marketCap":9802248},{"date":"2022-12-23","current":-0.277385,"twenty":-2.931175,"median":-1.828787,"eighty":-0.609107,"marketCap":6888851},{"date":"2022-12-30","current":-0.350528,"twenty":-2.922421,"median":-1.720438,"eighty":-0.602539,"marketCap":8705370},{"date":"2023-01-06","current":-0.528129,"twenty":-2.914318,"median":-1.701179,"eighty":-0.599086,"marketCap":13116093},{"date":"2023-01-13","current":-0.625812,"twenty":-2.901383,"median":-1.640222,"eighty":-0.598214,"marketCap":15542051},{"date":"2023-01-20","current":-0.537474,"twenty":-2.89628,"median":-1.593714,"eighty":-0.592596,"marketCap":13348179},{"date":"2023-01-27","current":-0.595898,"twenty":-2.881945,"median":-1.553241,"eighty":-0.588193,"marketCap":14799133},{"date":"2023-02-03","current":-0.596599,"twenty":-2.870663,"median":-1.486242,"eighty":-0.588133,"marketCap":14816544},{"date":"2023-02-10","current":-0.526768,"twenty":-2.863706,"median":-1.42398,"eighty":-0.586313,"marketCap":13082276},{"date":"2023-02-17","current":-0.468762,"twenty":-2.848902,"median":-1.399461,"eighty":-0.584214,"marketCap":11641708},{"date":"2023-02-24","current":-0.441736,"twenty":-2.844954,"median":-1.384759,"eighty":-0.580557,"marketCap":10970522},{"date":"2023-03-03","current":-0.407221,"twenty":-2.839687,"median":-1.363727,"eighty":-0.573877,"marketCap":10113328},{"date":"2023-03-10","current":-0.365678,"twenty":-2.830059,"median":-1.323559,"eighty":-0.571681,"marketCap":8487391},{"date":"2023-03-17","current":-0.351602,"twenty":-2.824263,"median":-1.26465,"eighty":-0.558885,"marketCap":8160680},{"date":"2023-03-24","current":-0.36426,"twenty":-2.823053,"median":-1.206065,"eighty":-0.555526,"marketCap":8454464},{"date":"2023-03-31","current":-0.433174,"twenty":-2.82256,"median":-1.197734,"eighty":-0.554288,"marketCap":10053957},{"date":"2023-04-06","current":-0.362853,"twenty":-2.813783,"median":-1.176594,"eighty":-0.551929,"marketCap":8421821},{"date":"2023-04-14","current":-0.39378,"twenty":-2.803676,"median":-1.167232,"eighty":-0.543935,"marketCap":9139635},{"date":"2023-04-21","current":-0.616007,"twenty":-2.802456,"median":-1.142264,"eighty":-0.542237,"marketCap":14297511},{"date":"2023-04-28","current":-0.749615,"twenty":-2.795658,"median":-1.130759,"eighty":-0.542237,"marketCap":17398569},{"date":"2023-05-05","current":-1.030897,"twenty":-2.792533,"median":-1.12978,"eighty":-0.542237,"marketCap":23927113},{"date":"2023-05-12","current":-0.857909,"twenty":-2.785189,"median":-1.11212,"eighty":-0.542237,"marketCap":19912059},{"date":"2023-05-19","current":-0.66061,"twenty":-2.784895,"median":-1.099694,"eighty":-0.542237,"marketCap":22131764},{"date":"2023-05-26","current":-0.689368,"twenty":-2.784617,"median":-1.093481,"eighty":-0.542237,"marketCap":23095208},{"date":"2023-06-02","current":-0.59563,"twenty":-2.783005,"median":-1.081055,"eighty":-0.542237,"marketCap":19954783},{"date":"2023-06-09","current":-0.56535,"twenty":-2.783005,"median":-1.073603,"eighty":-0.542237,"marketCap":18940360},{"date":"2023-06-16","current":-0.46547,"twenty":-2.778299,"median":-1.067361,"eighty":-0.537009,"marketCap":15594172},{"date":"2023-06-23","current":-0.471631,"twenty":-2.778299,"median":-1.056204,"eighty":-0.535561,"marketCap":15800590},{"date":"2023-06-30","current":-0.408153,"twenty":-2.778299,"median":-1.056204,"eighty":-0.530279,"marketCap":13673933},{"date":"2023-07-07","current":-0.408153,"twenty":-2.778299,"median":-1.049991,"eighty":-0.527943,"marketCap":13673933},{"date":"2023-07-14","current":-0.400351,"twenty":-2.767963,"median":-1.040671,"eighty":-0.525138,"marketCap":13412558},{"date":"2023-07-21","current":-0.424752,"twenty":-2.753666,"median":-1.037565,"eighty":-0.517797,"marketCap":14230050},{"date":"2023-07-28","current":-0.367142,"twenty":-2.7462,"median":-1.031352,"eighty":-0.513338,"marketCap":12299997},{"date":"2023-08-04","current":-0.520444,"twenty":-2.72702,"median":-1.02991,"eighty":-0.509117,"marketCap":17435901},{"date":"2023-08-11","current":-0.526302,"twenty":-2.711868,"median":-1.025139,"eighty":-0.506968,"marketCap":17632177},{"date":"2023-08-18","current":-0.441268,"twenty":-2.705547,"median":-1.018926,"eighty":-0.506341,"marketCap":15481463},{"date":"2023-08-25","current":-0.395459,"twenty":-2.698363,"median":-1.012713,"eighty":-0.500653,"marketCap":13874277},{"date":"2023-09-01","current":-0.406677,"twenty":-2.686058,"median":-1.011185,"eighty":-0.495076,"marketCap":14267873},{"date":"2023-09-08","current":-0.410417,"twenty":-2.679178,"median":-1.0065,"eighty":-0.490065,"marketCap":14399072},{"date":"2023-09-15","current":-0.361803,"twenty":-2.663656,"median":-0.998701,"eighty":-0.486015,"marketCap":12693487},{"date":"2023-09-22","current":-0.319733,"twenty":-2.64737,"median":-0.99096,"eighty":-0.481428,"marketCap":11217500},{"date":"2023-09-29","current":-0.374891,"twenty":-2.6344,"median":-0.979975,"eighty":-0.479527,"marketCap":13152683},{"date":"2023-10-06","current":-0.331886,"twenty":-2.586391,"median":-0.961814,"eighty":-0.473155,"marketCap":11643897},{"date":"2023-10-13","current":-0.2599,"twenty":-2.570012,"median":-0.948766,"eighty":-0.470551,"marketCap":9118319},{"date":"2023-10-20","current":-0.257095,"twenty":-2.562442,"median":-0.93004,"eighty":-0.466123,"marketCap":9019920},{"date":"2023-10-27","current":-0.213155,"twenty":-2.547669,"median":-0.926839,"eighty":-0.465203,"marketCap":7478333},{"date":"2023-11-03","current":-0.284207,"twenty":-2.537327,"median":-0.916368,"eighty":-0.459796,"marketCap":9971111},{"date":"2023-11-10","current":-0.284674,"twenty":-2.522616,"median":-0.909563,"eighty":-0.457732,"marketCap":9987511},{"date":"2023-11-17","current":-1.724678,"twenty":-2.512522,"median":-0.905115,"eighty":-0.457233,"marketCap":55550149},{"date":"2023-11-24","current":-1.737678,"twenty":-2.499195,"median":-0.905115,"eighty":-0.457233,"marketCap":55968869},{"date":"2023-12-01","current":-1.434343,"twenty":-2.488262,"median":-0.905115,"eighty":-0.457233,"marketCap":46198742},{"date":"2023-12-08","current":-1.404009,"twenty":-2.474488,"median":-0.905156,"eighty":-0.457318,"marketCap":45221729},{"date":"2023-12-15","current":-1.200341,"twenty":-2.467235,"median":-0.905156,"eighty":-0.457318,"marketCap":38661787},{"date":"2023-12-22","current":-1.100674,"twenty":-2.442132,"median":-0.905156,"eighty":-0.457318,"marketCap":35451602},{"date":"2023-12-29","current":-1.08334,"twenty":-2.443983,"median":-0.905115,"eighty":-0.457233,"marketCap":34893310},{"date":"2024-01-05","current":-0.936006,"twenty":-2.428413,"median":-0.905073,"eighty":-0.457148,"marketCap":30147819},{"date":"2024-01-12","current":-0.918673,"twenty":-2.412393,"median":-0.905073,"eighty":-0.457148,"marketCap":29589526},{"date":"2024-01-19","current":-0.810339,"twenty":-2.404358,"median":-0.892927,"eighty":-0.457063,"marketCap":26100195},{"date":"2024-01-26","current":-0.771338,"twenty":-2.387059,"median":-0.888825,"eighty":-0.457148,"marketCap":24844036},{"date":"2024-02-02","current":-0.788672,"twenty":-2.37056,"median":-0.880205,"eighty":-0.457148,"marketCap":25402329},{"date":"2024-02-09","current":-0.927339,"twenty":-2.356615,"median":-0.880205,"eighty":-0.457148,"marketCap":29868673},{"date":"2024-02-16","current":-0.936006,"twenty":-2.337219,"median":-0.879672,"eighty":-0.457148,"marketCap":30147819},{"date":"2024-02-23","current":-0.940339,"twenty":-2.328726,"median":-0.879672,"eighty":-0.457148,"marketCap":30287393},{"date":"2024-03-01","current":-0.96634,"twenty":-2.300906,"median":-0.879938,"eighty":-0.457233,"marketCap":31124832},{"date":"2024-03-08","current":-1.149635,"twenty":-2.292423,"median":-0.879938,"eighty":-0.457233,"marketCap":32709420},{"date":"2024-03-15","current":-1.020797,"twenty":-2.28505,"median":-0.879938,"eighty":-0.457233,"marketCap":29043709},{"date":"2024-03-22","current":-1.154591,"twenty":-2.265503,"median":-0.879938,"eighty":-0.457233,"marketCap":32850409},{"date":"2024-03-28","current":-1.466776,"twenty":-2.243401,"median":-0.879938,"eighty":-0.457233,"marketCap":41732708},{"date":"2024-04-05","current":-1.407312,"twenty":-2.221047,"median":-0.879672,"eighty":-0.457148,"marketCap":40040841},{"date":"2024-04-12","current":-1.486597,"twenty":-2.180807,"median":-0.879672,"eighty":-0.457148,"marketCap":42296664},{"date":"2024-04-19","current":-1.139725,"twenty":-2.137877,"median":-0.879672,"eighty":-0.457148,"marketCap":32427442},{"date":"2024-04-26","current":-1.223965,"twenty":-2.098382,"median":-0.879938,"eighty":-0.457233,"marketCap":34824253},{"date":"2024-05-03","current":-1.238831,"twenty":-2.057937,"median":-0.879938,"eighty":-0.457233,"marketCap":35247220},{"date":"2024-05-10","current":-1.284847,"twenty":-2.021354,"median":-0.879938,"eighty":-0.457233,"marketCap":37362053},{"date":"2024-05-17","current":-1.309089,"twenty":-2.016513,"median":-0.879938,"eighty":-0.457233,"marketCap":38066997},{"date":"2024-05-24","current":-1.27515,"twenty":-2.00909,"median":-0.879938,"eighty":-0.457233,"marketCap":37080075},{"date":"2024-05-31","current":-1.254146,"twenty":-1.990082,"median":-0.879938,"eighty":-0.457233,"marketCap":36469304},{"date":"2024-06-07","current":-1.189079,"twenty":-1.960297,"median":-0.879938,"eighty":-0.457233,"marketCap":34577227},{"date":"2024-06-14","current":-1.099149,"twenty":-1.931817,"median":-0.879672,"eighty":-0.457148,"marketCap":31962143},{"date":"2024-06-21","current":-0.869327,"twenty":-1.915649,"median":-0.873795,"eighty":-0.457063,"marketCap":25279149},{"date":"2024-06-28","current":-0.984238,"twenty":-1.838165,"median":-0.871006,"eighty":-0.45657,"marketCap":28620646},{"date":"2024-07-05","current":-0.914292,"twenty":-1.78555,"median":-0.871006,"eighty":-0.45657,"marketCap":26586692},{"date":"2024-07-12","current":-1.034199,"twenty":-1.735078,"median":-0.871006,"eighty":-0.45657,"marketCap":30073471},{"date":"2024-07-15","current":-1.069172,"twenty":-1.728145,"median":-0.871006,"eighty":-0.45657,"marketCap":31090448},{"date":"2024-08-02","current":-0.909296,"twenty":-1.662662,"median":-0.864872,"eighty":-0.454046,"marketCap":26441409},{"date":"2024-08-09","current":-0.884315,"twenty":-1.608559,"median":-0.862718,"eighty":-0.454046,"marketCap":25714997},{"date":"2024-08-16","current":-0.95111,"twenty":-1.559603,"median":-0.862694,"eighty":-0.454046,"marketCap":27037190},{"date":"2024-08-23","current":-0.975441,"twenty":-1.53615,"median":-0.862694,"eighty":-0.454046,"marketCap":27728866},{"date":"2024-08-30","current":-0.939122,"twenty":-1.512343,"median":-0.862694,"eighty":-0.454046,"marketCap":26696408},{"date":"2024-09-06","current":-1.001384,"twenty":-1.492267,"median":-0.862694,"eighty":-0.454046,"marketCap":28466336},{"date":"2024-09-13","current":-0.928745,"twenty":-1.474191,"median":-0.862694,"eighty":-0.454046,"marketCap":26401420},{"date":"2024-09-20","current":-0.985818,"twenty":-1.432089,"median":-0.862694,"eighty":-0.454046,"marketCap":28023854},{"date":"2024-09-27","current":-0.975441,"twenty":-1.407312,"median":-0.862694,"eighty":-0.454046,"marketCap":27728866},{"date":"2024-10-04","current":-0.98063,"twenty":-1.40121,"median":-0.862694,"eighty":-0.454046,"marketCap":27876360},{"date":"2024-10-11","current":-0.954687,"twenty":-1.384759,"median":-0.862694,"eighty":-0.454046,"marketCap":27138890},{"date":"2024-10-18","current":-1.136285,"twenty":-1.372625,"median":-0.862694,"eighty":-0.454046,"marketCap":32301179},{"date":"2024-10-25","current":-1.395711,"twenty":-1.357759,"median":-0.862694,"eighty":-0.454046,"marketCap":39675877},{"date":"2024-10-31","current":-1.416465,"twenty":-1.357759,"median":-0.862694,"eighty":-0.454046,"marketCap":40265853},{"date":"2024-11-08","current":-1.368657,"twenty":-1.3545,"median":-0.86267,"eighty":-0.453921,"marketCap":46534347},{"date":"2024-11-15","current":-1.232179,"twenty":-1.34292,"median":-0.86267,"eighty":-0.453921,"marketCap":41894069},{"date":"2024-11-22","current":-1.25821,"twenty":-1.324513,"median":-0.86267,"eighty":-0.453921,"marketCap":42779155},{"date":"2024-11-29","current":-1.284242,"twenty":-1.30929,"median":-0.86267,"eighty":-0.453921,"marketCap":43664241},{"date":"2024-12-06","current":-1.110696,"twenty":-1.296199,"median":-0.86267,"eighty":-0.453921,"marketCap":37763668},{"date":"2024-12-13","current":-1.041278,"twenty":-1.285359,"median":-0.86267,"eighty":-0.453921,"marketCap":35403439},{"date":"2024-12-20","current":-1.036939,"twenty":-1.275995,"median":-0.86267,"eighty":-0.453921,"marketCap":35255924},{"date":"2024-12-27","current":-1.401386,"twenty":-1.274124,"median":-0.86267,"eighty":-0.453921,"marketCap":47647128},{"date":"2025-01-03","current":-1.444773,"twenty":-1.274124,"median":-0.86267,"eighty":-0.453921,"marketCap":49122271},{"date":"2025-01-10","current":-1.700753,"twenty":-1.273658,"median":-0.862505,"eighty":-0.453796,"marketCap":57825617},{"date":"2025-01-17","current":-1.119373,"twenty":-1.270749,"median":-0.862505,"eighty":-0.453796,"marketCap":38058697},{"date":"2025-01-24","current":-1.158421,"twenty":-1.259946,"median":-0.862505,"eighty":-0.453796,"marketCap":39386326},{"date":"2025-01-31","current":-1.023923,"twenty":-1.251811,"median":-0.862505,"eighty":-0.453796,"marketCap":34813381},{"date":"2025-02-07","current":-1.049955,"twenty":-1.244683,"median":-0.862505,"eighty":-0.453796,"marketCap":35698467},{"date":"2025-02-14","current":-1.078156,"twenty":-1.230678,"median":-0.862505,"eighty":-0.453796,"marketCap":36657311},{"date":"2025-02-21","current":-1.171437,"twenty":-1.223965,"median":-0.862505,"eighty":-0.453796,"marketCap":39828869},{"date":"2025-02-28","current":-1.084664,"twenty":-1.208009,"median":-0.862505,"eighty":-0.453796,"marketCap":36878582},{"date":"2025-03-07","current":-0.862852,"twenty":-1.19988,"median":-0.862339,"eighty":-0.453672,"marketCap":34370838},{"date":"2025-03-14","current":-0.707361,"twenty":-1.197469,"median":-0.857909,"eighty":-0.453672,"marketCap":28177024},{"date":"2025-03-21","current":-0.625456,"twenty":-1.19159,"median":-0.84738,"eighty":-0.453672,"marketCap":24914421},{"date":"2025-03-28","current":-0.662686,"twenty":-1.186787,"median":-0.84096,"eighty":-0.453672,"marketCap":26397423},{"date":"2025-04-04","current":-0.621733,"twenty":-1.179955,"median":-0.833572,"eighty":-0.453672,"marketCap":24766121},{"date":"2025-04-11","current":-0.550997,"twenty":-1.179875,"median":-0.829063,"eighty":-0.453796,"marketCap":21948419},{"date":"2025-04-17","current":-0.671993,"twenty":-1.179875,"median":-0.82653,"eighty":-0.453796,"marketCap":26768173},{"date":"2025-04-25","current":-0.699915,"twenty":-1.179955,"median":-0.819087,"eighty":-0.453672,"marketCap":27880424},{"date":"2025-04-29","current":-0.536105,"twenty":-1.179955,"median":-0.816084,"eighty":-0.453672,"marketCap":21355218}],"updateTime":1746005083967}}}